Guardant Health Return on Equity

Guardant Health (GH) currently reports a ROE of 203.46%. That is above the Healthcare sector average of 22.01%. Use the charts on this page to explore Guardant Health's ROE history and peer comparisons.

Guardant Health's ROE of 203.46% is higher than the Healthcare sector average of 22.01%. That is roughly 824.4% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' ROE, but Guardant Health's current 203.46% should be judged against Healthcare norms (sector average: 22.01%) and against GH's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current ROE of 203.46%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 22.01%. From there, open related valuation or income-statement pages for Guardant Health, and consider following GH for alerts when major investors trade the stock.

Guardant Health is classified in the Healthcare sector. On ROE, it currently shows 203.46% versus a sector average near 22.01%. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing GH with unrelated industries.